Metabolic study of colorectal cancer that has spread to the liver
Part of Cancer, Digestive system clinical trials.
This study looks at tissue from colorectal cancer surgery to understand how cancer cells use energy, which may help find better treatments. It is open to adults having surgery for colorectal cancer or liver metastases from colorectal cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having surgery to remove colorectal cancer, or liver metastases from colorectal cancer.
- You have leftover tumor tissue from surgery that can be used for research.
- You sign a consent form allowing your tissue to be used for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study focuses on people with colon cancer (CRC) that has spread to the liver. It looks at factors that may affect liver metastases and could help doctors better understand who may benefit from future treatments.
This study collects tissue, blood, and imaging samples from people having surgery for colon cancer or related liver tumors, to learn more about the disease and potentially improve future treatments.
This study takes samples from colorectal cancer that has spread to the liver and grows them in the lab. The goal is to create models that can help researchers understand the cancer better and find new treatments.
This study compares two different types of liver surgery for people with colorectal cancer that has spread to the liver and who have specific genetic changes or a right-sided primary tumor. You will be randomly assigned to one surgery type, and researchers will track how well you do over time to see if one approach is better.
This study looks at your tumor's genetic makeup and a blood test after surgery to better predict if colorectal cancer that spread to the liver might come back early. The goal is to personalize follow-up care and potentially guide additional treatments.
This study compares different blood tests to find the best way to detect tiny bits of cancer DNA after surgery for stage III colorectal cancer. It aims to help doctors decide if additional chemotherapy is needed to prevent the cancer from coming back.
Hear when a new CRC (Colorectal Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.